AAAAAA
Results:
1-13
|
Results: 13
Authors:
RIPPLE GH
GOULD MN
STEWART JA
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
POMPLUN M
WILDING G
BAILEY HH
Citation: Gh. Ripple et al., PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY, Clinical cancer research, 4(5), 1998, pp. 1159-1164
Authors:
RIPPLE GH
GOULD MN
STEWART JA
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
POMPLUN M
WILDING G
BAILEY HH
Citation: Gh. Ripple et al., PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY, Clinical cancer research, 4(5), 1998, pp. 1159-1164
Authors:
BAILEY H
RIPPLE G
GOULD M
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
SIMON K
MORGAN K
TUTSCH K
POMPLUN M
WAHAMAKI A
MARNOCHA R
WILDING G
Citation: H. Bailey et al., PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS, Annals of oncology, 9, 1998, pp. 409-409
Authors:
BERLIN J
STEWART JA
STORER B
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
SIMON K
WILDING G
Citation: J. Berlin et al., PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF PENCLOMEDINE USING A NOVEL, 2-STAGE TRIAL DESIGN FOR PATIENTS WITH ADVANCED MALIGNANCY, Journal of clinical oncology, 16(3), 1998, pp. 1142-1149
Authors:
BAILEY HH
RIPPLE G
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
MAHVI D
SCHINK J
POMPLUN M
MULCAHY RT
WILDING G
Citation: Hh. Bailey et al., PHASE-I STUDY OF CONTINUOUS-INFUSION L-S,R-BUTHIONINE SULFOXIMINE WITH INTRAVENOUS MELPHALAN, Journal of the National Cancer Institute, 89(23), 1997, pp. 1789-1796
Authors:
BERLIN J
TUTSCH KD
HUTSON P
CLEARY J
RAGO RP
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
WILDING G
Citation: J. Berlin et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL CARBOXYAMIDOTRIAZOLE, A SIGNAL-TRANSDUCTION INHIBITOR, Journal of clinical oncology, 15(2), 1997, pp. 781-789
Authors:
ROBINS HI
RUSHING D
KUTZ M
TUTSCH KD
TIGGELAAR CL
PAUL D
SPRIGGS D
KRAEMER C
GILLIS W
FEIERABEND C
ARZOOMANIAN RZ
LONGO W
ALBERTI D
DOLEIRE F
QU RP
WILDING G
STEWART JA
Citation: Hi. Robins et al., PHASE-I CLINICAL-TRIAL OF MELPHALAN AND 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN CANCER-PATIENTS, Journal of clinical oncology, 15(1), 1997, pp. 158-164
Authors:
SCHULZ CA
MEHTA MP
ROBINS HI
BADIE B
ARZOOMANIAN R
SIMON K
ALBERTI D
FEIERABEND C
KUNUGI KA
WILDING G
KINSELLA TJ
Citation: Ca. Schulz et al., CONTINUOUS 28 DAY IODODEOXYURIDINE (IUDR) INFUSION AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR MALIGNANT GLIOMA - A PHASE-I CLINICAL AND THYMIDINE REPLACEMENT STUDY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 139-139
Authors:
CLEARY JF
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
STORER B
WITT P
CARBONE P
WILDING G
Citation: Jf. Cleary et al., A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 300-306
Authors:
MCGINN CJ
KUNUGI KA
TUTSCH KD
FEIERABEND C
ALBERTI D
LINDSTROM MJ
WILDING G
ARZOOMANIAN RZ
KINSELLA TJ
Citation: Cj. Mcginn et al., LEUCOVORIN MODULATION OF 5-IODODEOXYURIDINE RADIOSENSITIZATION - A PHASE-I STUDY, Clinical cancer research, 2(8), 1996, pp. 1299-1305
Authors:
SCHILLER JH
STORER B
TUTSCH K
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 12(2), 1994, pp. 241-248
Authors:
SCHILLER JH
STORER B
TUTSCH K
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
SPRIGGS D
Citation: Jh. Schiller et al., A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 21(5), 1994, pp. 9-14
Authors:
ROBINS HI
COHEN JD
SCHMITT CL
TUTSCH KD
FEIERABEND C
ARZOOMANIAN RZ
ALBERTI D
DOLEIRE F
LONGO W
HEISS C
RUSHING D
LOVE R
SPRIGGS D
Citation: Hi. Robins et al., PHASE-I CLINICAL-TRIAL OF CARBOPLATIN AND 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN CANCER-PATIENTS, Journal of clinical oncology, 11(9), 1993, pp. 1787-1794
Risultati:
1-13
|